Haleon PLC Sponsored ADR $HLN Shares Sold by Envestnet Portfolio Solutions Inc.

Envestnet Portfolio Solutions Inc. decreased its position in shares of Haleon PLC Sponsored ADR (NYSE:HLN) by 3.7% during the 2nd quarter, HoldingsChannel reports. The fund owned 90,609 shares of the company’s stock after selling 3,520 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in Haleon were worth $940,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Hanson & Doremus Investment Management boosted its position in shares of Haleon by 234.1% during the 2nd quarter. Hanson & Doremus Investment Management now owns 2,372 shares of the company’s stock valued at $25,000 after acquiring an additional 1,662 shares during the last quarter. Bartlett & CO. Wealth Management LLC boosted its position in shares of Haleon by 135.9% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 2,588 shares of the company’s stock valued at $27,000 after acquiring an additional 1,491 shares during the last quarter. Banque Transatlantique SA acquired a new position in shares of Haleon during the 1st quarter valued at about $27,000. Ransom Advisory Ltd acquired a new position in shares of Haleon during the 1st quarter valued at about $31,000. Finally, Deutsche Bank AG boosted its position in shares of Haleon by 267.8% during the 1st quarter. Deutsche Bank AG now owns 3,126 shares of the company’s stock valued at $32,000 after acquiring an additional 2,276 shares during the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Stock Up 3.0%

Shares of NYSE:HLN opened at $9.48 on Monday. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.87 and a quick ratio of 0.63. The firm has a market capitalization of $42.22 billion, a PE ratio of 24.31, a price-to-earnings-growth ratio of 2.77 and a beta of 0.20. The firm’s 50-day moving average is $9.41 and its two-hundred day moving average is $9.99. Haleon PLC Sponsored ADR has a 1 year low of $8.71 and a 1 year high of $11.42.

Haleon Increases Dividend

The firm also recently declared a semi-annual dividend, which was paid on Thursday, September 18th. Shareholders of record on Friday, August 15th were paid a dividend of $0.0555 per share. This represents a yield of 190.0%. This is a boost from Haleon’s previous semi-annual dividend of $0.05. The ex-dividend date was Friday, August 15th. Haleon’s payout ratio is currently 28.21%.

Analyst Upgrades and Downgrades

Several brokerages recently issued reports on HLN. The Goldman Sachs Group upgraded shares of Haleon from a “neutral” rating to a “buy” rating in a report on Wednesday, September 10th. Barclays lowered shares of Haleon from an “overweight” rating to an “equal weight” rating in a report on Tuesday, September 16th. Weiss Ratings restated a “hold (c)” rating on shares of Haleon in a report on Wednesday, October 8th. Finally, Wall Street Zen lowered shares of Haleon from a “buy” rating to a “hold” rating in a report on Saturday, July 12th. One equities research analyst has rated the stock with a Strong Buy rating, three have assigned a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $12.33.

Haleon Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.